13F

Stock

Alzamend Neuro, Inc.

ALZN · held by 13 managers

Reported value

$424.2K

Holders

13

+1 new · −0 exited

Holders’ est. mark

−$21

Price effect on 1 books still in the name

Largest holder

$211.7K

DRW Securities, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
DRW Securities, LLC116.3K$211.7KHeld
GEODE CAPITAL MANAGEMENT, LLC27.5K$50.1KHeld
UBS Group AG24.6K$44.7KHeld
Vanguard21.6K$39.3KHeld
MORGAN STANLEY18K$32.8KNew
XTX Topco Ltd12.5K$22.7KHeld
Clearstead Advisors, LLC10K$18.2KHeld
Tower Research Capital LLC (TRC)2.08K$3.79KHeld
BlackRock, Inc.437$795Held
BANK OF AMERICA CORP /DE/43$78−$21Cut−$10
SBI Securities Co., Ltd.22$40Held
Virtu Financial LLC12.6K$23Held
HARBOR INVESTMENT ADVISORY, LLC1$2Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.